Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 15 % of short-term debt in 2025; threshold 65 %.
-
Busy address KBO
24 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
VISMED from Leuven, company number BE0598725075, closed financial year 2025 with a result of € 3.8 million after tax. For that financial year VISMED recorded revenue of € 22.9 million and equity of € 13.4 million. Compared with financial year 2024, the result moved from € 6.3 million to € 3.8 million. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.
€ 13.4 million
▲ 40% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 3.8 million
▼ 39% vs 2024
Profit after tax over the fiscal year.
€ 223,077
▼ 79% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 12.9 million.
People and assets in 2025
€ 313,527
▲ € 265,527 vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 40.3 million
▼ 16% vs 2024
€ 507,504 is repaid this year. At this pace the long-term loan is gone in ≈ 39 years.
€ 1.6 million
▲ 111% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 28 days on average.
€ 403,362
▲ 44% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | - | € 35,338,394 | € 28,792,284 | € 22,937,636 | ▼ 20% |
| Gross margin | € 5,092,244 | - | - | - | |
| Profit after taxes | € 2,761,125 | € 210,515 | € 6,277,988 | € 3,849,819 | ▼ 39% |
| Equity | € 5,381,132 | € 5,591,646 | € 9,573,930 | € 13,423,749 | ▲ 40% |
| Total debts | € 51,519,503 | € 26,179,712 | € 50,827,611 | € 43,576,432 | ▼ 14% |
| Cash | € 1,279,370 | € 3,553,103 | € 1,074,826 | € 223,077 | ▼ 79% |
| Land & buildings | € 2,309,210 | € 6,035,068 | € 18,624,372 | € 30,862,048 | ▲ 66% |
| Retained profit | € 5,362,532 | € 5,573,046 | € 9,063,753 | € 12,913,572 | ▲ 42% |
| Bank debt | € 43,911,359 | € 22,045,485 | € 48,300,041 | € 40,336,740 | ▼ 16% |
| Balance sheet total | € 56,900,635 | € 31,771,358 | € 63,589,819 | € 60,441,463 | ▼ 5% |
Key figures of VISMED, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to VISMED?
What happened at VISMED in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 3.8 million (▼ 39% vs 2024). Source: NBB ↗
- New establishment in Leuven. KBO
- Start of the company according to the CBE. KBO
In short
From € 2.8 million profit in 2022 to € 3.8 million profit in 2025.
Paid € 1.5 million in corporate taxes since 2022.
Best year ever: 2024, with € 6.3 million profit.
Pays suppliers within 28 days on average.
A new publication or filing at VISMED? We notify you, reason included.
Follow VISMEDDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of Finance & Management Executives comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
VISMEDBehind VISMED are F.M.E BV and Tim Pauwels. The shares are held by Finance & Management Executives (99.7%).
Directors
According to the 2025 annual accounts
Tim Pauwels
Director
Also active at: Galerie Sint-Truiden, BURES, G.C.I., PS&U, Finance & Management Executives, HEAD OFFICE, A-VENUE, ANKAJO +31 more
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Naamsestraat 12
3000 Leuven
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 24 companies are registered at this address.
All companies at this address →PAT BOVI
€ 14,603 gross margin · 2025
BURES same network
€ 1.4 million gross margin · 2025
TIKI CONSTRUCT same network
€ 34,065 gross margin · 2025
AARTMAN same network
€ 114,559 gross margin · 2025
LEMCON same network
€ 986,594 gross margin · 2024
+19 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0598.725.075
- VAT number
- BE 0598.725.075
- Registered office
- Naamsestraat 12, 3000 Leuven
- Names & denominations
- VISMED
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 13 February 2015
- Peppol
- Active · Active since 20 Aug 2025
- Activities · NACE
Bemiddeling in verband met exploitatie van en handel in onroerend goed
Bemiddeling bij de aankoop, verkoop en verhuur van onroerend goed voor een vast bedrag of op contractbasis
Schatten en evalueren van onroerend goed voor een vast bedrag of op contractbasis
Ontwikkeling van niet-residentiële bouwprojecten